Methyl 5-bromo-2-(cyclohexylamino)-3-pyridinecarboxylate

Modify Date: 2025-09-05 17:07:35

Methyl 5-bromo-2-(cyclohexylamino)-3-pyridinecarboxylate Structure
Methyl 5-bromo-2-(cyclohexylamino)-3-pyridinecarboxylate structure
 Common Name Methyl 5-bromo-2-(cyclohexylamino)-3-pyridinecarboxylate
CAS Number 1268348-56-6 Molecular Weight 313.19
Density N/A Boiling Point N/A
Molecular Formula C13H17BrN2O2 Melting Point N/A
MSDS N/A Flash Point N/A

 Names

Name Methyl 5-bromo-2-(cyclohexylamino)-3-pyridinecarboxylate

 Chemical & Physical Properties

Molecular Formula C13H17BrN2O2
Molecular Weight 313.19

 Preparation

COC(=O)c1cc(Br)cnc1NC1CCCCC1
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.
Top Suppliers:I want be here
Related Compounds: More...
2-(3-Aminoazetidin-1-yl)-2,3-dimethylbutanenitrile
2090969-82-5
6-ethyl-N-(2-methylphenyl)-4-oxo-4H-chromene-2-carboxamide
874400-84-7
3-Isopropyl-6-methylimidazo[1,5-a]pyrazin-8(7h)-one
2031271-58-4
6-ethyl-N-(4-methylphenyl)-4-oxo-4H-chromene-2-carboxamide
874400-85-8
3-(7,8-Dihydro-6-methyl-8-oxoimidazo[1,5-a]pyrazin-3-yl)-3-methyl-1-pyrrolidinecarboxylic acid 1,1-dimethylethyl ester
2031271-88-0
N-(3,4-dimethylphenyl)-6-ethyl-4-oxo-4H-chromene-2-carboxamide
874400-86-9
3-(Azetidin-3-yl)-1,5-dimethylimidazolidine-2,4-dione
2089668-92-6
6-ethyl-N-(2-fluorophenyl)-4-oxo-4H-chromene-2-carboxamide
874400-90-5
3-(1,2,4-Oxadiazol-3-yl)cyclobutan-1-one
2092668-31-8
N-(2,4-dimethylphenyl)-6-ethyl-4-oxo-4H-chromene-2-carboxamide
874400-92-7
Chemsrc provides CAS#:1268348-56-6 MSDS, density, melting point, boiling point, structure, etc. Its name is Methyl 5-bromo-2-(cyclohexylamino)-3-pyridinecarboxylate>> amp version: Methyl 5-bromo-2-(cyclohexylamino)-3-pyridinecarboxylate

Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer

Copyright © 2024 ChemSrc All Rights Reserved